Sonnet Biotherapeutics Holdings Inc. buy me8
Start price
31.10.22
/
0%
€1.57
Target price
31.10.23
-
Performance (%)
74.57%
End price
01.11.22
€2.74
Summary
This prediction ended on 01.11.22 with a price of €2.74. With a performance of 74.57% the BUY prediction by me8 was a big success. This prediction was marked as speculative and is excluded from me8's performance statistics.Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Sonnet Biotherapeutics Holdings Inc. | - | - | - |
iShares Core DAX® | 2.758% | 0.818% | 17.073% |
iShares Nasdaq 100 | 2.595% | -1.326% | 31.625% |
iShares Nikkei 225® | 3.109% | 0.173% | 17.176% |
iShares S&P 500 | 1.862% | -0.531% | 26.703% |
According to me8 what are the pros and cons of Sonnet Biotherapeutics Holdings Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Very capable Management
Very good company culture
Cons
Few uniques
Comments by me8 for this prediction
In the thread Sonnet Biotherapeut. Hldgs.inc diskutieren
Buy Sonnet Biotherapeutics Holdings Inc.
In the thread Trading Sonnet Biotherapeutics Hldgs. Inc.
Buy beendet
Stopped prediction by me8 for Sonnet Biotherapeutics Holdings Inc.
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€1.45
09.01.23
09.01.23
-
09.01.24
09.01.24
-31.72%
21.01.23
21.01.23
Could be very worthwhile Investment >20% year
Very capable Management
Very good company culture
Few uniques
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€55.16
24.08.20
24.08.20
-
05.09.20
05.09.20
-48.22%
05.09.20
05.09.20
Could be very worthwhile Investment >20% year
Very capable Management
Very good company culture
Few uniques